AGAshton H. Goldman

Ashton H. Goldman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashton H. Goldman has a total of 63 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • How Is Platelet-rich Plasma Utilized by Outpatient Providers When Covered by Insurance Without Need for Preauthorization?

    by Aaron A. Olsen, Ashton H. Goldman, Vivek M. Abraham, George C. Balazs

    Background: TRICARE is the primary health insurer for US military personnel, military retirees, and their families. Between October 1, 2019 (FY2020) through September 30, 2024 (FY2024), TRICARE authorized private sector reimbursement of outpatient platelet-rich plasma (PRP) injections for knee osteoarthritis and lateral epicondylitis without the need for prior authorization, despite minimal evidence of efficacy for these conditions. We sought to describe utilization and reimbursement patterns for outpatient PRP injections covered under the TRICARE Provisional Coverage Program to illustrate potential usage patterns where PRP was generally covered without regard for scientific evidence of effectiveness. Questions/purposes: (1) What was the total number of, reimbursement for, and temporal variation of PRP injections reimbursed to nonmilitary providers during the TRICARE Provisional Coverage Program? (2) What proportion of reimbursed PRP injections met authorized use criteria under the Provisional Coverage Program? (3) What was the geographic variation in utilization and cost of PRP injections under the Provisional Coverage Program? Methods: The Military Data Repository (MDR) was queried for all paid claims by TRICARE for Current Procedural Terminology code 0232T (injection of platelet-rich plasma) administered at nonmilitary clinics between October 1, 2019, and September 30, 2024 (FY 2020 through 2024); there were 13,277 such claims. To the best of our knowledge, this is the only centralized location containing data on all such claims. Claims were excluded when the injections were performed in an inpatient setting, performed in conjunction with a surgical procedure, administered in an ambulatory surgery center, or the reason for the injection could not be ascertained from the listed ICD-10 diagnosis codes; after applying those exclusions, 95% (12,613) were further considered, encompassing 13,386 injections. Claims were considered to have “met criteria” if filed with an associated ICD-10 code for knee osteoarthritis or lateral epicondylitis. Claims were considered to have “potentially met criteria” if administered for any diagnosis of the knee or elbow. All other claims were categorized as “not meeting criteria.” Mean reimbursement (amount paid by TRICARE to providers) was calculated for the total cohort and for each US state individually. Results: The number of injections increased annually, from 657 injections in FY2020 to 4140 injections in FY2024. The mean reimbursement increased 266% over the study period from FY2020 (USD 667 per injection) to FY2024 (USD 1764 per injection). Most injections (92% [12,253 of 13,386]) definitively or potentially met TRICARE criteria for reimbursement. One clinic received more than USD 7 million in reimbursement, accounting for nearly one-third of the money reimbursed nationally. Conclusion: During the 5 years that outpatient PRP treatment was covered by TRICARE without preauthorization, utilization showed substantial year-on-year increases, with associated increases in reimbursement to providers. The value of these treatments is questionable given the weak evidence base for its use. The program allowed for one outlier clinic to receive millions of dollars while still technically adhering to requirements. Policymakers should consider both the efficacy of treatment and the potential for exploitation when considering coverage of newer treatments and institute administrative controls to protect against outlier behaviors. Level of Evidence: Level IV, therapeutic study.

  • Younger Age Is a Risk Factor for Discontinuing Military Service After THA

    by Skyler D. Md Walker, Vivek M. Md Abraham, Ileya Bs Yancey, George C. Md Balazs, Ashton H. Md Goldman

    Background: With improved implant survival, THA is becoming more common in younger patients. Despite similar patient-reported outcomes between younger and older cohorts, it remains unclear whether age at THA may limit a patient’s ability to return to their job. Evaluation of the return-to-duty rate in military personnel after THA may shed light on the potential functional status of civilian patients who are of a similar demographic in physically demanding professions. Questions/purposes: (1) What proportion of active-duty military personnel return to duty after THA? (2) What demographic and surgical factors were associated with this return-to-duty proportion? Methods: We performed a retrospective chart audit of all active-duty US military personnel who underwent primary THA between 2017 and 2020 at US military hospitals globally. A total of 452 patients underwent primary THA during the study period. Twenty-one percent (93 of 452) of patients with medical records lacking critical information for the primary analysis were excluded, leaving 79% (358) eligible for analysis. Most patients were men (85% [306 of 358]), and the median (range) age was 46 years (22 to 65). Approaches included direct anterior (58% [206]), posterior (40% [143]), and lateral (3% [9]). The most common indications were primary osteoarthritis (63% [226]), avascular necrosis (18% [64]), and secondary osteoarthritis attributed to dysplasia (15% [52]). Univariate analyses considered demographic and operative variables. Multivariable logistic regression analysis was utilized to assess independent factors for return to duty versus medical separation. Results: Ten percent (35 of 358) of patients underwent medical separation from service because of their hip after THA, with the remaining 90% returning to duty. After controlling for potentially confounding variables such as surgical approach, complications, and BMI, we found that decreasing age was associated with higher risk of medical separation, such that each year of increasing age was associated with a decreased risk of medical separation by 17% (OR 0.83 [95% CI 0.76 to 0.90]; p < 0.01). Patients serving in the US Navy were less likely to undergo separation from service than patients in the Army (OR 0.19 [95% CI 0.04 to 0.87]; p = 0.03). Complications and surgical approach were not found to be associated with increased odds of separation. Conclusion: When treating active-duty military patients who qualify for THA, one must consider the occupation and age implications that surgical intervention may have on the patient. Analysis of this unique patient population may allow for improved understanding of outcomes in the growing number of young active civilian patients who undergo THA. These data can potentially be applied to that population, especially those in physically demanding jobs that may be analogous to military duty. The results of this study would also be of use when providing an evidence-based preoperative risk assessment for these patients regarding their postoperative functional outcomes. Level of Evidence: Level III, therapeutic study.


  • The Relationship Between Age and 30-Day Outcomes Following Unicompartmental Versus Total Knee Arthroplasty

    by Graham E. Sullivan, Krista B. Highland, Gregory J. Booth, Alexander P. Dunnum, Ashton H. Goldman


  • Patient reported outcome measures (PROMs) as primary and secondary outcomes in total hip and knee arthroplasty randomized controlled trials: a systematic review

    by Charles R. Reiter, Vivek M. Abraham, Daniel L. Riddle, Nirav K. Patel, Ashton H. Goldman

    Background Significant heterogeneity exists regarding patient reported outcome measures (PROMs) used in total hip (THA) and knee (TKA) arthroplasty randomized controlled trials (RCTs). This study investigates the PROMs used as primary and secondary outcomes in contemporary arthroplasty RCTs. Methods A literature search identified THA and TKA RCTs that were published in top ten impact factor orthopaedic journals from 2017 to 2021. Screening identified 241 trials: 76 THA, 157 TKA, and eight combined. Data were extracted to identify PROMs utilized as either primary or secondary outcomes and the time period of measurement. Results Visual Analog Scale (VAS) Pain was the most reported primary PROM in THA (9.2%) and TKA (22.9%) trials. This was followed by Numeric Rating Scale (NRS) Pain (7.9%) and the Harris Hip score (6.6%) in THA trials and NRS Pain (4.5%) and the Knee Society score (4.5%) in TKA trials. Many THA (37.0%) and TKA (52.1%) trials did not clearly specify primary outcome time points. Only pain scales were reported at time points less than one week, while various joint-specific functional outcomes were reported at later time points. As secondary outcomes, the Harris Hip score (28.9%) was most common in THA trials and the Knee Society score (26.1%) was most common in TKA trials. Indeterminate primary or secondary outcomes were reported in 18.2% of studies. Conclusions Contemporary THA and TKA trials exhibit heterogeneity of PROMs as study outcomes after the first postoperative week. Our findings highlight the need for consensus in PROM reporting and better methodological reporting to improve the interpretability of RCT outcomes. PROSPERO registration number CRD42022337255.


  • Disparities in Demographics in Hip Arthroplasty Between U.S. Active Duty Military and the ACS-NSQIP Clinical Registry

    by Vivek M Abraham, Joshua M Junge, Greg Booth, Aaron A Olsen, George C Balazs, Ashton H Goldman

    Patient demographics, such as sex and age, are known risk factors for undergoing revision following primary total hip arthroplasty (THA). The military population is unique because of the increased rates of primary and secondary osteoarthritis of the hip. Treatment options are limited for returning patients to their line of duty; however, THA has been shown to be an effective option. The primary purpose of this study was to evaluate and contrast the demographic differences of patients undergoing primary THA between the U.S. active duty military population and the general population. The secondary goal was to identify the proportion of primary THA performed at the MTF within the military health system (MHS). This was an exempt study determined by the local institutional review board. A retrospective analysis of the MHS Data Repository (MDR) and the National Surgical Quality Improvement Program (NSQIP) was performed. The databases were used to identify the patients who underwent THA from January 1, 2015 to December 31, 2020. The MDR was used to identify demographics such as sex, age, setting of surgery, geographic location, previous military deployments, history of deployment-related injuries, branch of service, and rank. The NSQIP database was queried for sex and age. The median age of the population was compared using the Mann–Whitney U test and gender was compared using the Chi-square test. The MDR was used to evaluate 2,734 patients, whereas the NSQIP database was used to evaluate 223,832 patients. In the military population, patients who underwent THA were 87.7% male with an average age of 45 years, whereas in the general population as measured via the NSQIP database, 45.2% patients were male with an average age of 66.0 years. Comparing the two groups, we demonstrated that the military patients were significantly more likely to be younger (P < .001) and males (P < .001). Only 29.6% of primary THAs were performed within the MTF. Patients in the MHS are undergoing THA at a younger age and are more likely to be male compared to the general population. A significant portion of primary THAs in the MHS are also being performed at civilian institutions. These demographics may result in increased risk of revision; however, long-term studies are warranted to evaluate survivorship in this unique population.


  • The Surgical Instrument Sterilization Process

    by Vaughn Land, Samuel Dickerson, Ashton Goldman, Eric D. Shirley

    » The phases of the sterilization process for surgical equipment are cleaning, disinfection, and sterilization. » Following manufacturer and regulatory guidelines will minimize contamination throughout the sterilization process. » Immediate use steam sterilization, when used appropriately, is a reasonably safe option to be used at the discretion of the operating surgeon.


  • Open Access

    The Association Between Borderline Dysnatremia and Perioperative Morbidity and Mortality: Retrospective Cohort Study of the American College of Surgeons National Surgical Quality Improvement Program Database

    by Jacob H Cole, Krista B Highland, Scott B Hughey, Brendan J O'SHea, Thomas Hauert, Ashton H Goldman, George C Balazs, Gregory J Booth

    Background: Hyponatremia and hypernatremia, as conventionally defined (145 mEq/L, respectively), are associated with increased perioperative morbidity and mortality. However, the effects of subtle deviations in serum sodium concentration within the normal range are not well-characterized. Objective: The purpose of this analysis is to determine the association between borderline hyponatremia (135-137 mEq/L) and hypernatremia (143-145 mEq/L) on perioperative morbidity and mortality. Methods: A retrospective cohort study was performed using data from the American College of Surgeons National Surgical Quality Improvement Program database. This database is a repository of surgical outcome data collected from over 600 hospitals across the United States. The National Surgical Quality Improvement Program database was queried to extract all patients undergoing elective, noncardiac surgery from 2015 to 2019. The primary predictor variable was preoperative serum sodium concentration, measured less than 5 days before the index surgery. The 2 primary outcomes were the odds of morbidity and mortality occurring within 30 days of surgery. The risk of both outcomes in relation to preoperative serum sodium concentration was modeled using weighted generalized additive models to minimize the effect of selection bias while controlling for covariates. Results: In the overall cohort, 1,003,956 of 4,551,726 available patients had a serum sodium concentration drawn within 5 days of their index surgery. The odds of morbidity and mortality across sodium levels of 130-150 mEq/L relative to a sodium level of 140 mEq/L followed a nonnormally distributed U-shaped curve. The mean serum sodium concentration in the study population was 139 mEq/L. All continuous covariates were significantly associated with both morbidity and mortality (P<.001). Preoperative serum sodium concentrations of less than 139 mEq/L and those greater than 144 mEq/L were independently associated with increased morbidity probabilities. Serum sodium concentrations of less than 138 mEq/L and those greater than 142 mEq/L were associated with increased mortality probabilities. Hypernatremia was associated with higher odds of both morbidity and mortality than corresponding degrees of hyponatremia. Conclusions: Among patients undergoing elective, noncardiac surgery, this retrospective analysis found that preoperative serum sodium levels less than 138 mEq/L and those greater than 142 mEq/L are associated with increased morbidity and mortality, even within currently accepted “normal” ranges. The retrospective nature of this investigation limits the ability to make causal determinations for these findings. Given the U-shaped distribution of risk, past investigations that assume a linear relationship between serum sodium concentration and surgical outcomes may need to be revisited. Likewise, these results question the current definition of perioperative eunatremia, which may require future prospective investigations.


  • A history of shoulder instability is more common in young patients undergoing total shoulder arthroplasty

    by Jonathan K. Kallevang, Kyle Wieschhaus, Aaron A. Olsen, Ashton H. Goldman, James Hammond, George C. Balazs


  • AAOS Clinical Practice Guideline Summary: Prevention of Surgical Site Infection After Major Extremity Trauma

    by Ashton H. Goldman, Kevin Tetsworth

    Prevention of Surgical Site Infections After Major Extremity Trauma Evidence-Based Clinical Practice Guideline is based on a systematic review of current scientific and clinical research. This clinical practice guideline (CPG) is designed to assist qualified physicians and clinicians when making treatment decisions for adults (18 years or older) who have sustained major extremity trauma. The CPG workgroup defined major extremity trauma as an open fracture, a major/high-energy closed fracture, a degloving injury, Morel-Lavallée lesions, a low-energy or high-energy gunshot injury, a crush injury, a blast injury, or any other moderate-energy to high-energy injury. This guideline contains 14 recommendations that evaluate preoperative, perioperative, and postoperative interventions to limit the risk of surgical site infections after major extremity trauma while also identifying and evaluating potential patient-specific risk factors to consider. Another six options formulated with either low-quality evidence, no evidence, or conflicting evidence are also presented and discussed in the CPG. These include the use of incisional negative-pressure wound therapy for high-risk surgical incisions, the implementation of an orthoplastic team, the possible role of hyperbaric O2, the value of various preoperative skin preparations, and select modifiable and administrative risk factors.